| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Gleice K Silva-Cardoso, Willian Lazarini-Lopes, Eduardo Octaviano Primini, Jaime E Hallak, José A Crippa, Antônio W Zuardi, Norberto Garcia-Cairasco, Christie R A Leite-Paniss. Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats. Behavioural brain research. 2023-07-20. PMID:37474023. |
cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male wistar rats. |
2023-07-20 |
2023-08-14 |
rat |
| Laura Mills, James Freeman, Bevan Rowlan. Australian daily cannabis users' use of police avoidance strategies and compensatory behaviours to manage the risks of drug driving. Drug and alcohol review. 2023-06-16. PMID:37323052. |
australian daily cannabis users' use of police avoidance strategies and compensatory behaviours to manage the risks of drug driving. |
2023-06-16 |
2023-08-14 |
Not clear |
| Tapan A Patel, Frederick T Schubert, James M Zech, Jesse R Cougl. Prevalence and correlates of cannabis use among individuals with DSM-5 social anxiety disorder: Findings from a nationally representative sample. Journal of psychiatric research. vol 163. 2023-06-05. PMID:37276644. |
notably, we found that at the symptom level, at least weekly cannabis use was significantly related to fear or avoidance of social situations interfering with relationships in both samples. |
2023-06-05 |
2023-08-14 |
Not clear |
| Adriana Jesus Souza, Francisco S Guimarães, Felipe V Gome. Cannabidiol attenuates the expression of conditioned place aversion induced by naloxone-precipitated morphine withdrawal through the activation of 5-HT1A receptors. Behavioural brain research. 2023-05-20. PMID:37209879. |
cannabidiol attenuates the expression of conditioned place aversion induced by naloxone-precipitated morphine withdrawal through the activation of 5-ht1a receptors. |
2023-05-20 |
2023-08-14 |
mouse |
| Daryl Efron, Kaitlyn Taylo. Medicinal Cannabis for Paediatric Developmental, Behavioural and Mental Health Disorders. International journal of environmental research and public health. vol 20. issue 8. 2023-04-28. PMID:37107712. |
synthetic, transdermal cannabidiol gel has demonstrated efficacy for reducing social avoidance in a sub-group of children with fragile x syndrome. |
2023-04-28 |
2023-08-14 |
Not clear |
| Eleni Pilitsi, Brooke Kennamer, Nicole Trepanowski, Reina Gonzalez, Marcin Trojanowski, Tania Phillips, Christina S La. Cannabis arteritis presenting with Raynaud's and digital ulcerations: a case-based review of a controversial thromboangiitis obliterans-like condition. Clinical rheumatology. 2023-04-25. PMID:37097526. |
his symptoms resolved within 6 months and have not recurred for more than a year with continued avoidance of marijuana. |
2023-04-25 |
2023-08-14 |
Not clear |
| Paul S Regier, Michael J Gawrysiak, Kanchana Jagannathan, Anna Rose Childress, Teresa R Franklin, Reagan R Wetheril. Trauma exposure among cannabis use disorder individuals was associated with a craving-correlated non-habituating amygdala response to aversive cues. Drug and alcohol dependence reports. vol 5. 2023-02-27. PMID:36844163. |
trauma exposure among cannabis use disorder individuals was associated with a craving-correlated non-habituating amygdala response to aversive cues. |
2023-02-27 |
2023-08-14 |
Not clear |
| Jaqueline M Franzen, Isabel Werle, Felipe Vanz, Bruno Biscaia de Oliveira, Laura Maria Martins Nascimento, Francisco S Guimarães, Leandro J Bertogli. Cannabidiol attenuates fear memory expression in female rats via hippocampal 5-HT Neuropharmacology. 2022-11-05. PMID:36334768. |
cannabidiol attenuates fear memory expression in female rats via hippocampal 5-ht growing evidence from male rodent and human studies suggests that cannabidiol (cbd) modulates the expression of aversive memories and anxiety-related responses. |
2022-11-05 |
2023-08-14 |
human |
| Jaqueline M Franzen, Felipe Vanz, Isabel Werle, Francisco S Guimarães, Leandro J Bertogli. Cannabidiol impairs fear memory reconsolidation in female rats through dorsal hippocampus CB1 but not CB2 receptor interaction. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 64. 2022-09-01. PMID:36049316. |
male rodent findings indicate that cannabidiol (cbd), a relatively safe and effective treatment for several mental health conditions, can impair the reconsolidation of aversive memories. |
2022-09-01 |
2023-08-14 |
rat |
| Rachel Y Moon, Rebecca F Carlin, Ivan Han. Evidence Base for 2022 Updated Recommendations for a Safe Infant Sleeping Environment to Reduce the Risk of Sleep-Related Infant Deaths. Pediatrics. vol 150. issue 1. 2022-08-03. PMID:35921639. |
additional recommendations for sids risk reduction include human milk feeding; avoidance of exposure to nicotine, alcohol, marijuana, opioids, and illicit drugs; routine immunization; and use of a pacifier. |
2022-08-03 |
2023-08-14 |
human |
| Eric D Zaizar, Santiago Papini, Patrick O'Connor, Michael J Telc. Impact of cannabidiol-rich hemp extract oil on reconsolidation disruption of naturalistic interoceptive aversive memory in humans: Protocol for a randomized clinical trial. Contemporary clinical trials. 2022-07-10. PMID:35811050. |
preclinical experiments with rodents demonstrate that cannabidiol (cbd), the non-psychotomimetic constituent of the cannabis sativa plant, disrupts reconsolidation of aversive memories conditioned in the laboratory when administered within the memory reconsolidation window (< 6 h. |
2022-07-10 |
2023-08-14 |
Not clear |
| Rachel Y Moon, Rebecca F Carlin, Ivan Hand, Elie G Abu Jawdeh, Jeffrey Colvin, Michael H Goodstein, Fern R Hauck, Sunah S Hwang, James Cummings, Susan Aucott, Charleta Guillory, Mark Hudak, David Kaufman, Camilia Martin, Arun Pramanik, Karen Puopolo, Elizabeth Bundock, Lorena Kaplan, Sharyn Parks Brown, Marion Koso-Thomas, Carrie K Shapiro-Mendoza, Wanda Barfield, Russell Miller, Michael Narvey, Tim Jancelewicz, Ashley Lucke, Lisa Grisham, James Cout. Sleep-Related Infant Deaths: Updated 2022 Recommendations for Reducing Infant Deaths in the Sleep Environment. Pediatrics. 2022-06-21. PMID:35726558. |
additional recommendations for sids risk reduction include human milk feeding; avoidance of exposure to nicotine, alcohol, marijuana, opioids, and illicit drugs; routine immunization; and use of a pacifier. |
2022-06-21 |
2023-08-14 |
human |
| Skyler Sklenarik, Marc N Potenza, Robert S Astu. Avoidance tendencies toward cannabis stimuli in a college sample. Journal of addictive diseases. 2022-03-31. PMID:35356853. |
the sample did not demonstrate a significant approach or avoidance bias toward cannabis stimuli; instead, participants were significantly slower to approach and avoid cannabis stimuli relative to neutral stimuli. |
2022-03-31 |
2023-08-13 |
human |
| Skyler Sklenarik, Marc N Potenza, Robert S Astu. Avoidance tendencies toward cannabis stimuli in a college sample. Journal of addictive diseases. 2022-03-31. PMID:35356853. |
avoidance tendencies toward cannabis stimuli in a college sample. |
2022-03-31 |
2023-08-13 |
human |
| Melanie L Hill, Mallory Loflin, Brandon Nichter, Peter J Na, Sarah Herzog, Sonya B Norman, Robert H Pietrza. Cannabis use among U.S. military veterans with subthreshold or threshold posttraumatic stress disorder: Psychiatric comorbidities, functioning, and strategies for coping with posttraumatic stress symptoms. Journal of traumatic stress. 2022-03-11. PMID:35275431. |
veterans who used cannabis more than weekly also scored lower in cognitive functioning than veterans with no use, d = 0.25, or infrequent use, d = 0.71, and were substantially more likely to endorse avoidance coping strategies, ors = 8.2-12.2, including substance use, or = 4.4, and behavioral disengagement, ors = 2.7-9.1, to manage ptsd symptoms. |
2022-03-11 |
2023-08-13 |
human |
| Lívia Maria Bolsoni, José Alexandre S Crippa, Jaime Eduardo Cecílio Hallak, Francisco Silveira Guimarães, Antonio Waldo Zuard. Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder. Psychopharmacology. 2022-01-14. PMID:35029706. |
studies with cannabidiol (cbd) suggest that this compound has anxiolytic properties and may mediate the reconsolidation and extinction of aversive memories. |
2022-01-14 |
2023-08-13 |
human |
| Marta Kruk-Slomka, Grazyna Bial. Cannabidiol Attenuates MK-801-Induced Cognitive Symptoms of Schizophrenia in the Passive Avoidance Test in Mice. Molecules (Basel, Switzerland). vol 26. issue 19. 2021-11-18. PMID:34641522. |
cannabidiol attenuates mk-801-induced cognitive symptoms of schizophrenia in the passive avoidance test in mice. |
2021-11-18 |
2023-08-13 |
mouse |
| Robert C Schlauch, Mary J Breiner, Paul R Stasiewicz, Rita L Christensen, Alan R Lan. Women Inmate Substance Abusers' Reactivity to Visual Alcohol, Cigarette, Marijuana, and Crack-Cocaine Cues: Approach and Avoidance as Separate Dimensions of Reactivity. Journal of psychopathology and behavioral assessment. vol 35. issue 1. 2021-10-21. PMID:23543075. |
women inmate substance abusers' reactivity to visual alcohol, cigarette, marijuana, and crack-cocaine cues: approach and avoidance as separate dimensions of reactivity. |
2021-10-21 |
2023-08-12 |
human |
| Anna Brancato, Valentina Castelli, Gianluca Lavanco, Giuseppe Tringali, Vincenzo Micale, Martin Kuchar, Cesare D'Amico, Giuseppe Pizzolanti, Salvatore Feo, Carla Cannizzar. Binge-like Alcohol Exposure in Adolescence: Behavioural, Neuroendocrine and Molecular Evidence of Abnormal Neuroplasticity… and Return. Biomedicines. vol 9. issue 9. 2021-10-01. PMID:34572345. |
notably, subchronic cannabidiol, during withdrawal, attenuates social- and novelty-induced aversion and passive stress-coping and rectifies the hyper-responsive stress axis and nac dopamine and glutamate-related neuroplasticity. |
2021-10-01 |
2023-08-13 |
rat |
| Philip A Spechler, Jennifer L Stewart, Rayus Kuplicki, Martin P Paulu. Attenuated reward activations associated with cannabis use in anxious/depressed individuals. Translational psychiatry. vol 10. issue 1. 2021-06-18. PMID:32541777. |
individuals with mood/anxiety disorders may use cannabis for "self-medication," i.e., to induce positive mood or attenuate aversive mood states. |
2021-06-18 |
2023-08-13 |
human |